WS #12006

21:16→21:42 UTC

From 500 msgs · 5 key-dev

FDA approves Biogen's LEQEMBI IQLIK subcutaneous injection for early Alzheimer's, with US launch planned for late August 2026.

FDA Approval for Biogen Alzheimer's Drug

FDA approves Biogen's LEQEMBI IQLIK subcutaneous injection for early Alzheimer's, with US launch planned for late August 2026.